LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis C$8.65 0.00 (0.00%) As of 03:22 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsNews and Trends About Ondine Biomedical Stock (LON:OBI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ondine Biomedical alerts:Sign Up Key Stats Today's RangeC$8.61▼C$8.8050-Day RangeC$8.65▼C$11.2552-Week RangeC$7.50▼C$15.50Volume212,500 shsAverage Volume574,355 shsMarket CapitalizationC$5.72 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada. Read More Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OBI Stock News HeadlinesOndine Biomedical gets boost from study by University of Ottawa Heart InstituteNovember 17 at 8:00 AM | finance.yahoo.comOndine Biomedical (LON:OBI) Shares Climb 0.6% - Here's What HappenedNovember 17 at 2:05 AM | americanbankingnews.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 19 at 1:00 AM | Behind the Markets (Ad)Ondine Biomedical study reveals impact of 'infection tax'November 11, 2026 | finance.yahoo.comOndine Biomedical shares research that reinforces the potential of photodisinfectionNovember 9, 2026 | yahoo.comSolvonis Therapeutics, Ondine Biomedical, Caledonia Mining, ATOME - Small Cap SnapshotNovember 5, 2026 | uk.finance.yahoo.comOndine Biomedical's Steriwave adopted by Dartford and Gravesham NHS Trust after successful trialNovember 5, 2026 | finance.yahoo.comOndine reports negligible adverse event rate for nasal light therapy in 5,188-patient trialOctober 28, 2026 | finance.yahoo.comSee More Headlines OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed this year? Ondine Biomedical's stock was trading at C$8.75 at the beginning of the year. Since then, OBI stock has decreased by 1.1% and is now trading at C$8.65. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Industry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:OBI Previous SymbolLON:OBI CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($6.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$424.66 thousand Net Margins-1,150.26% Pretax MarginN/A Return on Equity-24,731.60% Return on Assets-159.71% Debt Debt-to-Equity Ratio-8.65 Current Ratio0.65 Quick Ratio8.26 Sales & Book Value Annual SalesC$2.88 million Price / Sales1,976.99 Cash FlowC$4.32 per share Price / Cash Flow1.99 Book ValueC$0.01 per share Price / Book996.57Miscellaneous Outstanding Shares661,218,000Free FloatN/AMarket CapC$5.69 billion OptionableNot Optionable Beta0.30 Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (LON:OBI) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredUnder 3 cents a nightBill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is ...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.